Although the Democrats want to pass a $10 billion COVID-19 relief package, they are at a standstill as Republicans back a vote on Title 42, an amendment that relaxes pandemic restrictions at the U.S. border.
Sens. Jeanne Shaheen, D-N.H., and Susan Collins, R-Maine, are working on legislation that would lower the cost of insulin. The legislation may include an item that prohibits pharmacy benefit managers to collect rebates on insulins with 2006 or similar pricing and another that places a $35-per-month out-of-pocket cap on insulin.
Democrats are also looking to revamp the Build Back Better bill, which includes an extension of enhanced Obamacare financial aid. Some lawmakers, though, are worried that increased premiums, created by a policy making it cheaper for Americans to purchase plans, may land just before the midterms.
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
